Harwin Peter Evan's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Jul 17, 2023
- Accession no.
- 0001104659-23-081729
- Filed
- Jul 17, 2023, 8:00 PM ET
- Trade date
- Jul 13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $50.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harwin Peter EvanCIK 0001663607 | Director |
| Fairmount Healthcare Fund L.P.CIK 0001686157 | Director |
| Fairmount Healthcare Fund II L.P.CIK 0001769651 | Director |
| Fairmount Funds Management LLCCIK 0001802528 | Director |
| Kiselak TomasCIK 0001830177 | Director |
| Fairmount Healthcare Co-Invest II L.P.CIK 0001982189 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | Common Stock | PPurchaseAcquired | +55,913 | $17.00 | +$950,521 | 55,913 | Indirect | |
| Jul 13, 2023 | Common Stock | PPurchaseAcquired | +1,992,734 | $17.00 | +$33,876,478 | 1,992,734 | Indirect | |
| Jul 13, 2023 | Common Stock | PPurchaseAcquired | +892,529 | $17.00 | +$15,172,993 | 892,529 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | Common Stock | AGrant or awardAcquired | +47,758 | $0.00 | $0 | 47,758 | Direct | |
| Jul 13, 2023 | Common Stock | AGrant or awardAcquired | +47,758 | $0.00 | $0 | 47,758 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.